Latest News for: hypertrophic cardiomyopathy

Edit

Understanding Your Risk For Hypertrophic Cardiomyopathy (Henry Ford Health System)

Public Technologies 05 Jun 2025
) Posted on June 5, 2025by Suzanna Mazur 8 Hypertrophic cardiomyopathy is a condition that causes an unexplained thickened left ventricle ...
Edit

Understanding The Growth Of The Hypertrophic Cardiomyopathy (HCM) Treatment Market By 2035

Pharmiweb 30 May 2025
Hypertrophic Cardiomyopathy (HCM) represents one of the most common inherited cardiac disorders, affecting approximately 1 in 500 individuals worldwide ... The Hypertrophic Cardiomyopathy treatment market ...
Edit

Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025 (Poxel SA)

Public Technologies 26 May 2025
Hypertrophic Cardiomyopathy (HCM) is a genetic disorder marked by myocardial hypertrophy, cardiac fibrosis, ventricular dysfunction, arrhythmias, and an increased risk of sudden cardiac death.
Edit

Efficacy and Safety of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy and Mild Symptoms (Cytokinetics Incorporated)

Public Technologies 19 May 2025
Patients with Obstructive Hypertrophic Cardiomyopathy and Mild Symptoms ... The subjectivity and heterogeneity of symptom burden in obstructive hypertrophic cardiomyopathy (oHCM) frequently results in ...
Edit

Associations Between Age and Sex and Cardiovascular Outcomes in Patients With Non-Obstructive Hypertrophic Cardiomyopathy (Cytokinetics Incorporated)

Public Technologies 19 May 2025
) ‌Associations Between Age and Sex and Cardiovascular Outcomes in Patients With Non-Obstructive Hypertrophic Cardiomyopathy ... hypertrophic cardiomyopathy (nHCM) have been limited in size.
  • 1
×